The transition of medication overuse status by acute medication categories in episodic or chronic migraine patients to non-overuse status after receiving anti-CGRP monoclonal antibodies: a systematic review and meta-analysis of phase 3 randomized control trial

Simple item page
dc.contributor.authorChananchida Sirilertmekasakul
dc.contributor.authorAkkanat Panto
dc.contributor.authorPattanan Lekhalawan
dc.contributor.authorPariyada Panyarachun
dc.contributor.authorPorpim Jindasakchai
dc.contributor.authorWanakorn Rattanawong
dc.date.accessioned2025-07-21T06:11:07Z
dc.date.issued2024-04-02
dc.identifier.doi10.1007/s10072-024-07496-7
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/13467
dc.subjectChronic Migraine
dc.subjectNeuroradiology
dc.subject.classificationMigraine and Headache Studies
dc.titleThe transition of medication overuse status by acute medication categories in episodic or chronic migraine patients to non-overuse status after receiving anti-CGRP monoclonal antibodies: a systematic review and meta-analysis of phase 3 randomized control trial
dc.typeReview

Files

Collections

All